Variations in the mRNA expression ofpoly(ADP-ribose) polymerases,poly(ADP-ribose) glycohydrolaseandADP-ribosylhydrolase 3in breast tumors and impact on clinical outcome-Reference-Cited by-同舟云学术

Variations in the mRNA expression ofpoly(ADP-ribose) polymerases,poly(ADP-ribose) glycohydrolaseandADP-ribosylhydrolase 3in breast tumors and impact on clinical outcome

Published:2013-08 Issue: Volume: Page:n/a-n/a
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bieche Ivan¹,Pennaneach Vincent,Driouch Keltouma¹,Vacher Sophie¹,Zaremba Tomasz,Susini Aurélie¹,Lidereau Rosette¹,Hall Janet

Affiliation:

1. Laboratoire d'Oncogénétique, Institut Curie-Hôpital René Huguenin; 92210; Saint-Cloud; France

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. (ADP-ribose)n participates in DNA excision repair;Durkacz;Nature,1980

3. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art;Vos;Biochem Pharmacol,2012

4. PARP-3, a DNA-dependent PARP with emerging roles in double-strand break repair and mitotic progression;Boehler;Cell Cycle,2011

5. Targeting poly(ADP-ribose) polymerase activity for cancer therapy;Megnin-Chanet;Cell Mol Life Sci,2010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring homologous recombination repair and base excision repair pathway genes for possible diagnostic markers in hematologic malignancies;Molecular Genetics and Genomics;2023-10-20

2. The role of poly (ADP‐ribose) glycohydrolase in phosphatase and tensin homolog deficiency endometrial cancer;Journal of Obstetrics and Gynaecology Research;2023-02-09

3. Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers;Nature Communications;2022-11-07

4. Pleiotropic role of PARP1: an overview;3 Biotech;2021-12-04

5. Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy;Cancers;2021-10-03